Key result
Hypertension is linked to ~6.4-fold higher odds of 5-year major cardiovascular events in transient STEMI.
Why the study?
Five-year clinical outcomes and baseline factors associated with MACE in patients presenting with transient STEMI needed evaluation.
Cohort (n=52)
No
Patients presenting with transient STEMI face a non-negligible 21.2% five-year MACE risk despite pre-angiography ST-segment resolution, with older age, hypertension, and hyperlipidemia identifying those at higher risk.
Answers are grounded in this paper and cite their sources.
Risk stratification by age and comorbidities may aid transient STEMI follow-up; these associations leave open the need for prospective validation before guiding practice.
Aim: This study aimed to evaluate five-year clinical outcomes and investigate baseline factors associated with major adverse cardiovascular events (MACE) in patients presenting with transient ST-segment elevation myocardial infarction (STEMI).Material and Methods: This retrospective, single-center, observational study included 52 patients who presented between January 2019 and December 2020 with ST-segment elevation on the initial electrocardiogram followed by complete resolution before coronary angiography. The primary outcome was five-year MACE, defined as a composite of cardiovascular death, acute coronary syndrome, revascularization, and ischemic cerebrovascular events. Follow-up data were obtained from hospital records and the national electronic health record system. Patients with and without MACE were compared, and associated factors were examined using univariable logistic regression.Results: The median age was 54.5 years, and 80.8% of patients were male. During five-year follow-up, MACE occurred in 11 patients (21.2%). All-cause mortality was 7.7%, cardiovascular mortality was 1.9%, and acute coronary syndrome and revascularization each occurred in 15.4%. Patients with MACE were older (63.0 vs. 51.0 years; p=0.003) and more frequently had hypertension (72.7% vs. 29.3%; p=0.014) and hyperlipidemia (45.5% vs. 12.2%; p=0.025). In univariable analysis, age (OR: 1.09; 95% CI: 1.02-1.17; p=0.016), hypertension (OR: 6.44; 95% CI: 1.46-28.53; p=0.014), and hyperlipidemia (OR: 6.00; 95% CI: 1.32-27.19; p=0.020) were significantly associated with five-year MACE.Conclusion: Long-term cardiovascular risk was not negligible after transient STEMI despite resolution of ST-segment elevation. Age, hypertension, and hyperlipidemia were associated with five-year MACE in univariable analyses and may help identify patients at higher long-term cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2026) conducted a cohort in Transient ST-segment elevation myocardial infarction (STEMI) (n=52). Transient STEMI and baseline risk factors (age, hypertension, hyperlipidemia) was evaluated on Five-year major adverse cardiovascular events (MACE: composite of cardiovascular death, acute coronary syndrome, repeat coronary revascularization, and ischemic cerebrovascular events) (OR 6.44 for hypertension, 95% CI 1.46-28.53, p=0.014). Transient STEMI patients had a 21.2% 5-year major cardiovascular events rate, with hypertension, hyperlipidemia, and older age associated with events.
Synapse has enriched 10 related papers. Consider them for comparative context: